International

Harris, Trump neck to neck in new poll

Darpan News Desk , 24 Jul, 2024 12:24 PM

Washington, July 24 (IANS) According to a latest poll, the race between Ex President Donald Trump and Vice President Kamala Harris is at razor's edge in the aftermath of President Biden’s decision to drop out.

Trump got support of 49% of voters while Harris had the backing of 47% of the voters.

A defining goal of my presidency will be to build up the middle class.

When the middle class is strong, America is strong.
— Kamala Harris (@KamalaHarris) July 24, 2024

The news was not great for Harris among young voters, with Trump having the backing of 58% of those in the 18-34 age bracket. Harris, on the other hand, just had 39% of support an astounding 19 point lead for Trump.

Harris will now be gearing up for the Democratic National Convention next month before she takes on Trump in the 2024 election in November.

Prev Next

MORE International ARTICLES

Trump supporters mass in D.C. as Biden era begins

Several Republican lawmakers will formally object to president-elect Joe Biden's win, citing phoney allegations of election fraud — a futile exercise that will likely do little beyond delaying the inevitable.

Trump supporters mass in D.C. as Biden era begins

Fauci: US could soon give 1 million vaccinations a day

Vaccinations have already begun speeding up, reaching roughly half a million injections a day, he pointed out.

Fauci: US could soon give 1 million vaccinations a day

Trump call ratchets up political tension in U.S.

That demand is sure to reverberate Tuesday, when two run-off elections in Georgia will decide whether Democrats or Republicans control the Senate.

Trump call ratchets up political tension in U.S.

'Relieved': US health workers start getting COVID-19 vaccine

Shipments of precious frozen vials of vaccine made by Pfizer Inc. and its German partner BioNTech began arriving at hospitals around the country Monday.

'Relieved': US health workers start getting COVID-19 vaccine

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.